Bausch Health Cos Current Ratio 2010-2023 | BHC
Bausch Health Cos current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Bausch Health Cos Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-12-31 |
$5.60B |
$4.30B |
1.30 |
| 2023-09-30 |
$5.05B |
$4.22B |
1.20 |
| 2023-06-30 |
$4.46B |
$3.97B |
1.13 |
| 2023-03-31 |
$4.24B |
$3.92B |
1.08 |
| 2022-12-31 |
$4.25B |
$3.94B |
1.08 |
| 2022-09-30 |
$4.01B |
$3.83B |
1.05 |
| 2022-06-30 |
$5.42B |
$5.00B |
1.08 |
| 2022-03-31 |
$5.84B |
$4.77B |
1.22 |
| 2021-12-31 |
$5.61B |
$5.20B |
1.08 |
| 2021-09-30 |
$5.32B |
$5.44B |
0.98 |
| 2021-06-30 |
$5.45B |
$5.52B |
0.99 |
| 2021-03-31 |
$5.39B |
$4.90B |
1.10 |
| 2020-12-31 |
$5.34B |
$4.91B |
1.09 |
| 2020-09-30 |
$5.67B |
$4.73B |
1.20 |
| 2020-06-30 |
$5.28B |
$4.72B |
1.12 |
| 2020-03-31 |
$5.50B |
$4.89B |
1.13 |
| 2019-12-31 |
$6.97B |
$6.25B |
1.12 |
| 2019-09-30 |
$4.31B |
$3.74B |
1.15 |
| 2019-06-30 |
$4.47B |
$3.71B |
1.21 |
| 2019-03-31 |
$4.28B |
$3.94B |
1.09 |
| 2018-12-31 |
$4.21B |
$3.84B |
1.10 |
| 2018-09-30 |
$4.74B |
$4.16B |
1.14 |
| 2018-06-30 |
$4.64B |
$4.07B |
1.14 |
| 2018-03-31 |
$4.72B |
$3.99B |
1.18 |
| 2017-12-31 |
$4.75B |
$4.27B |
1.11 |
| 2017-09-30 |
$5.94B |
$4.73B |
1.26 |
| 2017-06-30 |
$5.99B |
$4.47B |
1.34 |
| 2017-03-31 |
$5.33B |
$4.25B |
1.26 |
| 2016-12-31 |
$5.08B |
$3.61B |
1.41 |
| 2016-09-30 |
$5.67B |
$3.90B |
1.46 |
| 2016-06-30 |
$5.82B |
$4.23B |
1.38 |
| 2016-03-31 |
$6.23B |
$4.60B |
1.36 |
| 2015-12-31 |
$5.51B |
$5.31B |
1.04 |
| 2015-09-30 |
$7.00B |
$4.65B |
1.50 |
| 2015-06-30 |
$6.35B |
$4.29B |
1.48 |
| 2015-03-31 |
$16.19B |
$3.10B |
5.23 |
| 2014-12-31 |
$4.13B |
$2.71B |
1.53 |
| 2014-09-30 |
$4.41B |
$3.14B |
1.40 |
| 2014-06-30 |
$5.16B |
$2.50B |
2.07 |
| 2014-03-31 |
$3.95B |
$2.56B |
1.54 |
| 2013-12-31 |
$3.89B |
$2.51B |
1.55 |
| 2013-09-30 |
$3.85B |
$2.85B |
1.35 |
| 2013-06-30 |
$4.53B |
$1.76B |
2.57 |
| 2013-03-31 |
$2.37B |
$1.65B |
1.44 |
| 2012-12-31 |
$2.78B |
$1.82B |
1.52 |
| 2012-09-30 |
$1.71B |
$1.16B |
1.48 |
| 2012-06-30 |
$1.63B |
$1.05B |
1.55 |
| 2012-03-31 |
$1.53B |
$0.96B |
1.60 |
| 2011-12-31 |
$1.36B |
$0.92B |
1.47 |
| 2011-09-30 |
$1.10B |
$0.86B |
1.27 |
| 2011-06-30 |
$1.05B |
$0.76B |
1.37 |
| 2011-03-31 |
$1.28B |
$0.66B |
1.93 |
| 2010-12-31 |
$1.02B |
$0.69B |
1.47 |
| 2010-09-30 |
$1.30B |
$0.85B |
1.54 |
| 2010-06-30 |
$0.41B |
$0.23B |
1.77 |
| 2010-03-31 |
$0.34B |
$0.21B |
1.63 |
| 2009-12-31 |
$0.34B |
$0.25B |
1.38 |
| 2009-09-30 |
$0.25B |
$0.22B |
1.14 |
| 2009-06-30 |
$0.25B |
$0.22B |
1.13 |
| 2009-03-31 |
$0.47B |
$0.23B |
2.03 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.143B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
